1910 Genetics

1910 Genetics is a biotechnology company developing life-changing therapies for rare neurodegenerative, neuropathic, and hematological diseases. Our lead indication is sickle cell pain, and we’re solving the world’s opioid crisis by developing novel, first-in-class, non-opioid therapeutics that are efficacious in pain relief, but without the addiction potential and societal stigma of opioids.


VISIT WEBSITE Back to Portfolio